Delray Beach, Fla. – Delray Medical Center announces the appointment of Dr. Mahdi Taha, DO, FACOI, FACP, to the position of medical director of medical oncology at the hospital. In his role, Dr. Taha will work in collaboration with medical peers, colleagues, and hospital leadership, serving as a liaison to medical staff committees, identifying current and future technology requirements, advising on the modifications of existing programs and the development of new programs or services, and establishing methods to improve overall efficiency. He will also develop medical education programs and establish methods to improve overall efficiency.

“We welcome Dr. Taha to his new role as Medical Director of Medical Oncology for Delray Medical Center,” said Maggie Gill, chief executive officer of the Palm Beach Health Network and Delray Medical Center. “We encourage our community to seek care quickly for any oncologic needs, and for the public to get regular cancer screenings if you have a family history, or are at high risk for certain cancers, where a delay in treatment can affect the outcome.”

Dr. Taha specializes in head and neck cancers including Oropharynx, Nasopharynx, Salivary Gland Carcinomas, and Thyroid. He also specializes in skin cancers including melanoma, basil, cell carcinoma, squamous cell carcinoma and genitourinary carcinomas including prostate, bladder, renal-pelvis, testicular and renal cell.

Prior to joining Delray Medical Center, Dr. Taha worked for Cancer Treatment Centers of America (CTCA) in Newman, Georgia, as the lead medical oncologist for head and neck, genitourinary, melanoma and salivary gland carcinomas. He also served as CTCA’s vice president of quality chairman. Before his time at CTCA, Dr. Taha was an adjunct professor at the Morehouse School of Medicine. Dr. Taha completed an observership in genitourinary oncology, and head and neck thoracic oncology at MD Andersen.

Dr. Taha earned his medical degree from New York College of Osteopathic Medicine. After completing his residency in internal medicine at the Oklahoma State University Medical Center in Tulsa, Oklahoma, he was awarded a fellowship at Cancer Treatment Centers of America through Oklahoma State University where he was named medical oncology chief fellow.  He received his Bachelor of Arts in Biology from Kean University, in Union, New Jersey where he graduated Magna Cum Laude.

Dr. Taha is affiliated with Florida Cancer Specialists. His office will be located at 5130 Linton Blvd Suite B-4, in Delray Beach.